• Home
  • NEW DAY MEDICINE
  • 9 (71) 2024
  • 15 -9 (71) 2024 - Narziyev I.I. - CLINICAL AND DIAGNOSTIC CRITERIALS OF LIVER FIBROSIS FORMATION IN PATIENTS WITH CHRONIC VIRAL HEPATITIS C WITH EXTRAHEPATIVE MANIFESTATIONS

15 -9 (71) 2024 - Narziyev I.I. - CLINICAL AND DIAGNOSTIC CRITERIALS OF LIVER FIBROSIS FORMATION IN PATIENTS WITH CHRONIC VIRAL HEPATITIS C WITH EXTRAHEPATIVE MANIFESTATIONS

CLINICAL AND DIAGNOSTIC CRITERIALS OF LIVER FIBROSIS FORMATION IN PATIENTS WITH CHRONIC VIRAL HEPATITIS C WITH EXTRAHEPATIVE MANIFESTATIONS

Narziyev I.I.- Bukhara State Medical Institute named after Abu Ali ibn Sina

Resume

It was established that among patients of the first group with cryoglobulinemia, extrahepatic manifestations are more common; in addition, in these patients, higher stages of liver fibrosis and extrahepatic manifestations were more often recorded, this phenomenon suggests that the presence of cryoglobulins in the blood of patients is an aggravating factor in the course and outcome of chronic viral hepatitis C.

Key words: Chronic hepatitis C, extrahepatic manifestations, cryoglobulinemic vasculitis, hemorrhagic vasculitis.

First page

70

Last page

75

For citation:Narziyev I.I. - CLINICAL AND DIAGNOSTIC CRITERIALS OF LIVER FIBROSIS FORMATION IN PATIENTS WITH CHRONIC VIRAL HEPATITIS C WITH EXTRAHEPATIVE MANIFESTATIONS//New Day in Medicine 9(71)2024 70-75 https://newdayworldmedicine.com/en/new_day_medicine/9-71-2024

List of References

  1. Ахмедова М.Д. Определение эффективности гепатопротекторов при коротком курсе лечения в комплексной терапии хронических вирусных гепатитов В и С //Проблемы биологии и медицины. - Самарканд, 2014;3(79):83-87.
  2. Облокулова З.И. Внепеченочные проявления хронического вирусного гепатита С 2(40)2022 229-232 https://cutt.ly/YATZBLc
  3. Рахимова В.Ш., Эгамова И.Н., Ярмухамедова Н.А. Суставной синдром как внепеченочные проявления хронического вирусного гепатита С //Проблемы биологии и медицины. 2020;2(118):99-101.
  4. Carrat F, Fontaine H, Dorival C. et all. French ANRS CO22 Hepathercohort. Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study. //Lancet. 2019;393:1453-1464.
  5. Oblokulova Z.I., Oblokulov A.R., Jalilova A.S. (2022) Diagnostic significance of hepatic fibrosis in patients with extrahepatic chronic viral hepatitis C //Central Asian journal of medical and natural sciences. 2022;3(3):438-443.
  6. Galossi A, Guarisco R, Bellis L, Puoti C. Extrahepatic manifestations of chronic HCV infection. //J Gastrointestin Liver Dis. 2007;1(16):65-73.
  7. Martinello M, Hajarizadeh B, Grebely J, Dore GJ, Matthews GV. Management of acute HCV infection in the era of direct-acting antiviral therapy. Nat Rev //Gastroenterol Hepatol. 2018;15:412-424.
  8. Obloqulov A.R., Oblokulova Z.I., Elmurodova A.A. et al. Virologic response in the treatment of infection with antiviral drugs. //World Journal of Pharmaceutical Research ISSN 2277-7105. 2020;87-92.
  9. Romano C, Cuomo G, Ferrara R, Del Mastro A, Esposito S, Sellitto A, Adinolfi LE. Uncommon immune-mediated extrahepatic manifestations of HCV infection. //Expert Rev Clin Immunol. 2018;14:1089-1099.
  10. Spearman CW, Dusheiko GM, Hellard M, Sonderup M. Hepatitis C. //Lancet. 2019;394:1451-1466.

    file

    download